Cytena, the specialist for single-cell technologies, is continuing its growth with the establishment of its subsidiary Cytena Bioprocess Solutions in Taiwan. Cytena Bioprocess Solutions is developing an innovative technology, which enables considerable reductions in time and increases in efficiency for cell line development.
Cytena and Molecular Devices expand their partnership to launch the f.sight and c.sight in North America
Freiburg, Germany - Molecular Devices, LLC, a leader in protein and cell biology technologies, announced an expansion in its partnership with cytena GmbH to launch the x.sight series in North America. Building on cytena`s success of the single-cell printer system, the new family evolves both the ease of use for image-based isolation and documentation of single cells and adds fluorescent sorting for further enrichment of monoclonal cell lines.
The "Mono-cy-clone" project was funded by the Federal Ministry of Education and Research with 1.5 million euros as part of the "KMU-innovativ: Biotechnologie-BioChance" programme from January 2016 to July 2019. With the help of the project, the single-cell printer already launched by cytena in 2015 could be further developed.
- Two private investors and High-Tech Gründerfonds (HTGF) are convinced of the importance of single-cell isolation for the production of biopharmaceuticals and for genetic analysis in research and diagnostics.
- EUR 3 million will be invested in the further development of the technology, the expansion of the sales organization and in opening up further applications for Cytena's single-cell printers.